B. Hüsing

发表

Medium and Long-term Opportunities and Risks of the Biotechnological Production of Bulk Chemicals from Renewable Resources

Martin Kumar Patel, A. L. Roes, M. Crank, 2006 .

Translational research policies: disruptions and continuities in biomedical innovation systems in Austria, Finland and Germany

Bärbel Hüsing, Etienne Vignola-Gagné, Elina Rantanen, 2012, Journal of Community Genetics.

PHP159 Structures for the Role of Health Technology Assessment in Translational Research

Uwe Siebert, Petra Schnell-Inderst, Theresa Hunger, 2011 .

Human tissue-engineered products: Potential socio-economic impacts of a new European regulatory framework for authorisation, supervision and vigilance

B. Bührlen, M. Nusser, E. Rodríguez-Cerezo, 2005 .

Translational research policies: disruptions and continuities in biomedical innovation systems in Austria, Finland and Germany

Daniela Lehner, B. Hüsing, E. Rantanen, 2012, Journal of Community Genetics.

Medium and long-term opportunities and risk of the biotechnological production of bulk chemicals from renewable resources - The potential of white biotechnology

Martin Kumar Patel, B. G. Hermann, F. Terragni, 2006 .

Human Tissue Engineered Products - Today's Markets and Future Prospects

Sibylle Gaisser, B. Bührlen, S. Gaisser, 2003 .

Transition to the bioeconomy – Analysis and scenarios for selected niches

J. Köhler, E. Schirrmeister, S. Wydra, 2021 .

The impact of regionalised RTDI policy measures in Germany: the Network RNA Technologies Berlin (RiNA) as an example

T. Stahlecker, B. Hüsing, 2009 .

EU policies in personalized medicine-related technologies.

Christien Enzing, Etienne Vignola-Gagné, Sibylle Gaisser, 2009, Personalized medicine.

Identification of starting points for exposure assessment in the post-use phase of nanomaterial-containing products

Katrin Ostertag, Bärbel Hüsing, Katrin Ostertag, 2008 .